Yet they claim this paper shows a "reduced mortality with shorter regimens." If anything, the data published on shorter regimens (most notably the Nunn et al trial published in the New England Journal of Medicine) showed a trend toward higher mortality among people treated with a shorter regimen, especially if they were also living with HIV.
← all excerpts
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.
1
—
—